Investigating causes of heterogeneity in systematic reviews

Statistics in Medicine

Volumn 21, Issue 11, 2002, Pages 1503-1511

  Glasziou, P P ^a   Sanders, S L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Effect modification; Heterogeneity; Interaction; Meta analysis; Systematic review

Indexed keywords

AGE; ARTICLE; ARTIFACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FACTORIAL ANALYSIS; FOLLOW UP; GENDER; HUMAN; INDIVIDUALIZATION; OUTCOMES RESEARCH; POPULATION RESEARCH; RELIABILITY; REVIEW; TREATMENT OUTCOME;

CONTROLLED CLINICAL TRIALS; FEMALE; HUMANS; MALE; META-ANALYSIS; RESEARCH DESIGN; REVIEW LITERATURE;

EID: 0037098215     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1183     Document Type: Article

References (23)

1. Invited Commentary: Benefits of heterogeneity in meta-analysis of data from epidemiologic studies
2. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes
3. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials
4. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
5. Meta-analysis adjusting for compliance: The example of screening for breast cancer
6. Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: Implications for the interpretation and design of thromboprophylaxis trials
7. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
8. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
9. Single dose oral aspirin for acute pain
10. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
11. Menstrual cycle variation in mammographic breast density: So who cares?
12. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: Contrasts in hypotensive interactions
13. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
14. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS Study: A randomized controlled trial
15. Antibiotics for acute otitis media in children
16. How should meta-regression analyses be undertaken and interpreted?
17. An evidence based approach to individualising treatment
18. Large trials with simple protocols: Indications and contraindications
19. The relation between treatment benefit and underlying risk in meta-analysis
20. Investigating underlying risk as a source of heterogeneity in meta-analysis